
Click here to Sign up and Subscribe
Dec 10, 2024
Sai Life Sciences Ltd. IPO – A Detailed Analysis - English
India’s pharmaceutical research and manufacturing services sector is on a strong growth trajectory, projected to grow at a CAGR of 9-10% and touch ~₹4.5 lakh crore by 2028. This growth is driven by increasing global demand for generic medicines, outsourcing of R&D and manufacturing. Sai Life Sciences, a player in drug discovery, development, and manufacturing, is riding this wave with its IPO. But does it hold the right potential for listing gains or long-term growth? Let’s dive into its business, financials, and valuations to find out.
Related Videos
-1750747376481-3.webp&w=3840&q=75)
HDB Financial Services - A Detailed Analysis - Hindi
Jun 24, 2025
-1750422860298-3.webp&w=3840&q=75)
Kalpataru Ltd. IPO - A Detailed Analysis - Hindi
Jun 20, 2025
-1749792282020-3.webp&w=3840&q=75)
Oswal Pumps Ltd. IPO - A Detailed Analysis – Hindi
Jun 13, 2025
-1749210367772-3.webp&w=3840&q=75)
Stock of the Month : June 2025 - Hindi
Jun 6, 2025
-1748953474916-3.webp&w=3840&q=75)
Stock #5 Quarterly Update Q4FY25 – Hindi
Jun 3, 2025
-1748865849093-3.webp&w=3840&q=75)
Stock #7 Quarterly Update Q4FY25 – Hindi
Jun 2, 2025
-1748437447126-3.webp&w=3840&q=75)
Stock #2 Quarterly Update Q4FY25 – Hindi
May 28, 2025
-1748420066997-3.webp&w=3840&q=75)
Stock #3 Quarterly Update Q4FY25 – Hindi
May 28, 2025
-1748352607983-3.webp&w=3840&q=75)
Stock #13 Quarterly Update Q4FY25 – Hindi
May 27, 2025
-1748258555052-3.webp&w=3840&q=75)
Stock #9 Quarterly Update Q4FY25 - Hindi
May 26, 2025